Ucwaningo Lokuphepha Nokusebenza Kahle lwe-Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

I-Glioblastoma CAR T Izivivinyo zokwelashwa kwamaseli
Lolu wucwaningo oluvulekile, lwengalo eyodwa, lokwenyuka komthamo kanye nethamo eliningi ukuze kuhlolwe ukuphepha, ukubekezelelana kanye nempumelelo yokuqala ye-B7-H3-targeting Chimeric Antigen Receptor-T (CAR-T) cell therapy ezigulini ezine-glioblastomas eqhubekayo. Ucwaningo luphinde luhlele ukuhlola I-Maximum Tolerated Dose (MTD) futhi lunqume Umthamo Onconyiwe Wesigaba II (RP2D) sokwelashwa kweseli ye-CAR-T.

Yabelana ngalokhu okuthunyelwe

March 2023:

Uhlobo lokufunda : Ukungenelela (Isivivinyo Somtholampilo)
Ukubhaliswa Okulinganiselwe : Abahlanganyeli abangu-30
Isabelo: N/A
Imodeli Yokungenela: Ukunikezwa Okulandelanayo
Incazelo Yemodeli Yokungenela: idizayini ethi “3+3” isetshenziselwa ukunquma I-Maximum Tolerated Dose (MTD) kanye nomthamo onconywayo wesigaba sesi-2 (RP2D)
Ukufihla: Akukho (Vula ilebula)
Inhloso Eyinhloko: Ukwelashwa
Isihloko Esisemthethweni: Ucwaningo Oluvuliwe, Ngengalo Eyodwa, Isigaba 1 Sokuhlola Ukuphepha/Ukuphumelela Kokuqala kanye Nokunquma Umthamo Ophakeme Obekezeleleke We-B7-H3-Targeting CAR-T Cell Therapy Ekwelapheni I-Glioblastomas Ephindaphindiwe
Idethi yangempela yokuqala yokufunda : Januwari 27, 2022
Idethi Yokuqeda Okuyisisekelo Elinganiselwe : Disemba 31, 2024
Usuku Olulinganiselwe Lokuphothula : Disemba 31, 2024

Isigaba sokwenyuka komthamo:

Idizayini yokwenyuka komthamo othi “3+3” isetshenziselwa ukunquma i-MTD ne-R2PD. I-Anti-B7-H3 i-autologous Amaseli e-CAR-T zazinikezwa kabili ngeviki ezigulini imithamo elandelayo yomjikelezo ngamunye, nemijikelezo emi-4 njengesifundo esisodwa. Umthamo 1: Iziguli ezi-3 ngethamo lezigidi ezingama-20 amaseli ngomjikelezo ngamunye. Umthamo 2: Iziguli ezi-3 ngethamo lezigidi ezingama-60 amaseli ngomjikelezo ngamunye. Umthamo 3: Iziguli ezi-3 ngethamo lezigidi ezingama-150 amaseli ngomjikelezo ngamunye. Umthamo 4: Iziguli ezi-3 ngethamo lezigidi ezingama-450 amaseli ngomjikelezo ngamunye. Umthamo 5: Iziguli ezi-3 ngethamo lezigidi ezingama-900 amaseli ngomjikelezo ngamunye.

Isigaba sokuqinisekisa i-R2PD:

Nquma i-R2PD ngokusekelwe emiphumeleni yocwaningo lwangaphambilini lokwenyuka komthamo; Yelapha ezinye iziguli eziyi-12 nge-anti-B7-H3 autologous Amaseli e-CAR-T njalo ngeviki ku-R2PD ukuze kuqinisekiswe ukuphepha kwe-R2PD.

Esigabeni ngasinye somthamo, uma iziguli zibonisa ukubekezelelana nokusabela ku- ukwelashwa, lezi ziguli zazizothola izifundo eziningana ze ukwelashwa ngokubona kwe-PI.

Imigomo

Izindlela zokufaka

  1. Owesilisa noma owesifazane, oneminyaka eyi-18-75 (kuhlanganise neminyaka eyi-18 nengama-75 ubudala)
  2. Iziguli ezine-glioblastoma ebuyele emuva, njengoba kuqinisekiswe i-positron emission tomography (PET) noma i-histological pathology
  3. A >= 30% staining extent of B7-H3 in his/her primary/recurrent isisu tissue by the immunochemical method;
  4. Isilinganiso sesikali se-Karnofsky >=50
  5. Ukutholakala ekuqoqeni i-peripheral blood mononuclear cells (PBMCs)
  6. Amanani anele aselabhorethri kanye nokusebenza kwezitho ezanele;
  7. Iziguli ezinamandla okuzala/ukuba ngubaba kufanele zivume ukusebenzisa ukuvimbela inzalo okuphumelelayo kakhulu.

Izindlela zokukhishwa

  1. Abesifazane abakhulelwe noma abancelisayo
  2. Contraindication to bevacizumab
  3. Zingakapheli izinsuku ezi-5 ngaphambi kokumnika kweseli ye-CAR-T, abantu abathola ukuphathwa kwe-steroids okuhlelekile ngomthamo omkhulu kuno-10mg/d we-prednisone noma imithamo elinganayo yezinye i-steroids (ngaphandle kwe-corticosteroid ehogeliwe)
  4. I-Comorbid nezinye izifo ezimbi ezingalawuleki
  5. I-Active immunodeficiency virus (HIV), igciwane le-hepatitis B, igciwane le-hepatitis C noma isifo sofuba;
  6. Subjects receiving the placement of a i-carmustine slow-release wafer within 6 months before the enrollment;
  7. Izifo ze-Autoimmune;
  8. Ukuthola ukwelashwa kwe-immunosuppressive yesikhathi eside ngemuva kokufakelwa kwesitho;
  9. Izifo zengqondo ezinzima noma ezingalawuliwe noma isimo esingase sandise izehlakalo ezimbi noma siphazamise ukuhlolwa kwemiphumela;
  10. Ayitholakali ebuthi noma imiphumela engemihle ngokwelashwa kwangaphambilini;
  11. Izihloko ezibambe iqhaza kolunye ucwaningo lokungenelela phakathi nenyanga eyodwa ngaphambi kokubhaliswa, noma ezithole ezinye izindlela zokwelapha zamaseli e-CAR-T noma ukwelashwa kweseli okushintshiwe ngofuzo ngaphambi kokubhaliswa.
  12. Izihloko ezinezimo zezokwelapha ezithinta ukusayina imvume ebhaliwe enolwazi noma ukuthobela izinqubo zocwaningo, okuhlanganisa, kodwa kungagcini nje, izifo zemithambo yenhliziyo, ukungasebenzi kahle kwe-renal/ukwehluleka, i-pulmonary embolism, ukuphazamiseka kokuhlangana, ukutheleleka kwesistimu okusebenzayo, ukutheleleka okungalawuleki, njll. . al., noma iziguli ezingazimisele noma ezingakwazi ukuthobela izinqubo zocwaningo;
  13. Izihloko ezinezinye izimo ezingaphazamisa ukubamba iqhaza kwecala ngokubona komseshi.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela Nezinselele
Ukwelashwa kwe-CAR T-Cell

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela kanye Nezinselele

Ukwelashwa kwe-CAR T-cell okusekelwe kumuntu kuguqula ukwelashwa komdlavuza ngokushintsha izakhi zofuzo amaseli omzimba esiguli ukuze aqondise futhi abhubhise amaseli omdlavuza. Ngokusebenzisa amandla esimiso somzimba sokuzivikela ezifweni, lezi zindlela zokwelapha zinikeza ukwelashwa okunamandla futhi okuqondene nomuntu okungahle kube nokuxolelwa okuhlala isikhathi eside ezinhlotsheni ezihlukahlukene zomdlavuza.

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton